IRIS
CATURANO, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.793
AS - Asia 1.915
NA - Nord America 1.133
SA - Sud America 334
AF - Africa 20
OC - Oceania 2
Totale 8.197
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.985
US - Stati Uniti d'America 1.094
SG - Singapore 652
CN - Cina 477
HK - Hong Kong 302
BR - Brasile 271
IT - Italia 260
IE - Irlanda 242
VN - Vietnam 150
KR - Corea 120
DE - Germania 98
IN - India 86
GB - Regno Unito 59
JP - Giappone 31
FR - Francia 26
AR - Argentina 24
MX - Messico 19
ID - Indonesia 15
SE - Svezia 15
FI - Finlandia 13
CA - Canada 12
PL - Polonia 12
AT - Austria 11
NL - Olanda 11
ES - Italia 10
TR - Turchia 10
EC - Ecuador 9
CO - Colombia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
LT - Lituania 7
PK - Pakistan 7
BD - Bangladesh 6
BE - Belgio 6
GR - Grecia 6
IL - Israele 6
IQ - Iraq 6
IR - Iran 6
UA - Ucraina 6
EG - Egitto 5
MA - Marocco 5
PE - Perù 5
ZA - Sudafrica 5
JO - Giordania 4
UY - Uruguay 4
AZ - Azerbaigian 3
CH - Svizzera 3
KG - Kirghizistan 3
LB - Libano 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
JM - Giamaica 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
Totale 8.197
Salva come PNG Salva come JPEG
Città #
Moscow 1.422
Singapore 325
Hong Kong 300
Dublin 228
Santa Clara 195
Hefei 144
Chandler 132
Seoul 119
The Dalles 115
Naples 80
Bengaluru 67
New York 64
Ashburn 59
Ho Chi Minh City 54
Munich 42
Beijing 41
Dallas 38
São Paulo 28
Hanoi 24
Princeton 22
Roxbury 22
Cambridge 20
Los Angeles 19
Falkenstein 15
Bremen 13
Da Nang 12
Salerno 12
Belo Horizonte 10
Stockholm 10
Amsterdam 9
Atlanta 9
Boston 9
Brooklyn 9
Milan 9
Caserta 8
Frankfurt am Main 8
Nuremberg 8
Chennai 7
Des Moines 7
Ercolano 7
Helsinki 7
Istanbul 7
Liveri 7
Mexico City 7
Bexley 6
Brussels 6
Florence 6
Guarulhos 6
Houston 6
Hải Dương 6
Lahore 6
Napoli 6
Boardman 5
Changsha 5
Curitiba 5
Denver 5
Jacksonville 5
Nanjing 5
Rio de Janeiro 5
Rome 5
Tokyo 5
Warsaw 5
Amman 4
Baghdad 4
Biên Hòa 4
Brno 4
Bắc Ninh 4
Chicago 4
Damietta 4
Duncan 4
Haiphong 4
Lappeenranta 4
London 4
Manchester 4
Nonantola 4
Paris 4
Pelotas 4
Quito 4
San Francisco 4
Shenzhen 4
Tel Aviv 4
Tianjin 4
Toronto 4
Vienna 4
Wroclaw 4
Andover 3
Baku 3
Beaverton 3
Bogotá 3
Boydton 3
Brasília 3
Can Tho 3
Casablanca 3
Chengdu 3
Columbus 3
Dhaka 3
Eboli 3
Florianópolis 3
Goiânia 3
Guangzhou 3
Totale 3.985
Salva come PNG Salva come JPEG
Nome #
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 160
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 154
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 142
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 141
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 140
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 135
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 132
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 132
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 129
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 128
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 126
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 126
Cardiovascular benefits from gliflozins: Effects on endothelial function 123
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 121
HCC and molecular targeting therapies: Back to the future 121
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 118
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 117
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 116
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 116
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 116
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 114
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 112
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 109
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 107
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 107
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 104
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 103
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 102
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 102
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 102
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 102
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 102
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives 101
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 101
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 100
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 100
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 100
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 100
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 98
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 98
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 97
Polypharmacy and major adverse events in atrial fibrillation 97
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 96
Brugada syndrome and COVID-19 vaccines 96
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 94
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 94
null 93
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 92
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 91
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 91
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 90
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 87
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 87
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 87
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 87
Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk 86
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact 84
Insulin resistance and cancer: molecular links and clinical perspectives 83
Antioxidant and Antidiabetic Potential of the Antarctic Lichen Gondwania regalis Ethanolic Extract: Metabolomic Profile and In Vitro and In Silico Evaluation 83
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 82
Clinical Utilization and Performance of Bempedoic Acid in an Italian Real-World Setting: Insight from Campania Region 82
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 81
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 81
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 79
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model 79
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 79
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry 77
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 76
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 76
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 76
Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures 75
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 75
Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects 75
High HDL Cholesterol: a risk factor for Diabetic Retinopathy? Findings from NO BLIND study 73
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 71
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 64
Right ventricular electrocardiographic abnormalities among hospitalized COVID-19 patients: Simple marker of worst clinical outcome 63
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 61
The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management 60
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 60
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 59
Metabolic Dysfunction-Associated Steatotic Liver Disease in Klinefelter Syndrome: High Prevalence Uncovers an Unmet Need 57
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 55
Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad 51
Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum 49
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling 47
When the dual-chamber pacing system is the optimal choice for Brugada patients in need of implantable cardiac defibrillator 44
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 41
Totale 8.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.929
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 4 6 4 3 3 5 3
2021/2022197 11 1 8 19 33 8 4 4 11 16 29 53
2022/2023498 28 28 15 19 67 30 5 31 230 11 10 24
2023/2024363 34 17 13 25 77 63 9 9 8 28 30 50
2024/20251.371 13 17 5 26 209 146 215 125 195 120 120 180
2025/20265.846 377 443 384 305 637 3.700 0 0 0 0 0 0
Totale 8.320